JBIC funds Ajinomoto's deal to buy US gene therapy group Forge
JBIC has agreed a loan of up to JPY57 billion (just over $362 million) with Ajinomoto to allow the Japanese biotech company to acquire US-based Forge Biologics Holdings. The co-financing amount is JPY97 billion.Through the deal, Ajinomoto aims to combine Forge's gene therapy CDMO platform with...